https://idataresearch.com/wp-content/uploads/2016/04/ReportIcon-Cell-MS.jpg

Orthobiologics Market Analysis, Size, Trends | Japan | 2020-2026 | MedSuite

  • Year: 2020
  • Scope: 2016-2026
  • Region: Japan
  • Pages: 187
  • Published Date: 02/14/2020
  • Type: MedSuite

By 2020, the Japanese orthobiologics market size was valued at $426.9 million, with over 221,000 bone grafting procedures performed every year. The market size is expected to fluctuate over the forecast period with a -0.4% compound annual growth rate (CAGR).

Throughout this medical market research, we analyzed 16 orthobiologics companies across Japan and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts.

While this MedSuite report contains all of the Japanese Orthopedic Biomaterials market data and analysis, each of the market segments is also available as stand-alone MedCore reports. This allows you to get access to only the market research that you need.

DATA TYPES INCLUDED

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • Orthobiologics Procedure Volumes
  • Market Forecasts Until 2026, and Historical Data to 2016
  • Competitive Analysis with Market Shares for Each Segment
  • Market Drivers & Limiters for Each Orthopedic Biomaterials Device market
  • Recent Mergers & Acquisitions
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios and SWOT for Top Competitors

Market Value and Industry Trends

A lack of product differentiation across similar injection cycle products has led to commoditization, which has stifled innovation and the further development of new products. The prices of HA viscosupplementation products in Japan have drastically decreased since their introduction and are among the lowest in the world.

Japan Orthobiologics Market Size by Segment, 2016-2026

Surgical procedures that require the use of orthopedic biomaterials are generally associated with diseases and indications that become more prevalent in the population with an increase in age, such as osteoarthritis of the spine and knee. In 2019, approximately 29% of the Japanese population were aged 65 and over; this proportion is projected to grow steadily over the forecast period, as further cohorts of baby boomers turn 65. Growth of this population is expected to stimulate growth across all segments of the orthopedic biomaterials market.

In August 2018, Medtronic received PMDA approval for its Grafton® DBM allograft product, which is the first DBM allograft to be approved in Japan. Grafton® was commercially launched in February 2019. The growth of this product will be primarily driven by spine procedures and other orthopedic procedures that it is indicated for.

Competitive Analysis

India Orthopedic Biomaterials Market Leaders

By 2020, the leading competitor in the Japanese orthopedic biomaterials market was Seikagaku, which was attributed to its dominant position in the HA viscosupplementation market. The company’s portfolio includes the five-injection ARTZ® product line.

Chugai was the second-leading competitor in the Japanese market, which was attributed to its second-leading position in the HA viscosupplementation market. The company’s portfolio includes the Suvenyl® product line.

Segments Covered

Click on each title to view more detailed market segmentation.

  • Procedure Volumes for Orthopedic Biomaterials DevicesMedPro – The complete procedural analysis for each segment of the Japanese Orthopedic Biomaterials market.
  • Orthopedic Bone Graft Substitute Market – MedCore – This market is further segmented by Indication, including Spine, Trauma, Large Joint Reconstruction, Craniomaxillofacial, and Oncology.
  • Hyaluronic Acid Viscosupplementation Market – MedCore – This market is categorized by Treatment Type, including Three-Injection and Five-Injection.

Detailed Market Segmentation


DON’T SEE THE SEGMENT OR DATA YOU NEED?

Feel free to contact us or send a request by pressing one of the buttons below.

TABLE OF CONTENTS FOR JAPANESE ORTHOPEDIC BIOMATERIALS MARKET REPORT SUITE

TABLE OF CONTENTS I
LIST OF FIGURES VII
LIST OF CHARTS XII
EXECUTIVE SUMMARY 1
JAPANESE ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 3
MARKET TRENDS 5
MARKET DEVELOPMENTS 6
PROCEDURE NUMBERS 7
MARKETS INCLUDED 8
VERSION HISTORY 8
RESEARCH METHODOLOGY 9
Step 1: Project Initiation & Team Selection 9
Step 2: Prepare Data Systems and Perform Secondary Research 12
Step 3: Preparation for Interviews & Questionnaire Design 14
Step 4: Performing Primary Research 15
Step 5: Research Analysis: Establishing Baseline Estimates 17
Step 6: Market Forecast and Analysis 18
Step 7: Identify Strategic Opportunities 20
Step 8: Final Review and Market Release 21
Step 9: Customer Feedback and Market Monitoring 22

PRODUCT ASSESSMENT

2.1 INTRODUCTION 23
2.2 PRODUCT PORTFOLIOS 23
2.2.1 Bone Graft Substitutes 24
2.2.2 Growth Factors 30
2.2.2.1 Other Products 33
2.2.3 Hyaluronic Acid Viscosupplementation (HAV) 35
2.3 REGULATORY ISSUES AND RECALLS 38
2.3.1 Bone Graft Substitutes 38
2.3.1.1 Allografts 38
2.3.1.1.1 MTF 38
2.3.1.2 DBM 38
2.3.1.2.1 AlloSource 38
2.3.1.2.2 SeaSpine 39
2.3.1.2.3 RTI Surgical 39
2.3.1.3 Synthetics 39
2.3.1.3.1 Abyrx 39
2.3.1.3.2 Zimmer Biomet 40
2.3.2 Growth Factors 40
2.3.2.1.1 Medtronic 40
2.3.3 Hyaluronic Acid Viscosupplementation 41
2.3.3.1 Three-injection 41
2.3.3.1.1 Ferring Pharmaceuticals 41
2.4 CLINICAL TRIALS 42
2.4.1 Bone Graft Substitutes 42
2.4.1.1 Allografts 42
2.4.1.1.1 Providence Medical Technology 42
2.4.1.1.2 The University of Texas Health Science 42
2.4.1.1.3 University of Winchester 43
2.4.1.2 BDM 43
2.4.1.2.1 K2M 43
2.4.1.2.2 Zimmer Biomet 44
2.4.1.3 Synthetics 44
2.4.1.3.1 Baxter 44
2.4.1.3.2 Bonesupport 45
2.4.1.3.3 DePuy Synthes 45
2.4.1.3.4 NuVasive 47
2.4.1.3.5 RTI surgical 47
2.4.1.3.6 Sunstar GUIDOR 48
2.4.1.4 Other materials and comparison 49
2.4.1.4.1 Seoul National University Hospital. 49
2.4.1.4.2 Sewon Cellontech 49
2.4.1.4.3 SurgaColl Technologies Limited 50
2.4.1.4.4 University of Colorado 50
2.4.1.4.5 University of Padova 51
2.4.2 Growth Factors 51
2.4.2.1.1 Bioventus 51
2.4.2.1.2 Cerapedics 52
2.4.2.1.3 CGBio 52
2.4.2.1.4 Isto 53
2.4.2.1.5 Medtronic 53
2.4.2.1.6 NuVasive 55
2.4.2.1.7 Wright 55
2.4.2.1.8 Others 56
2.4.3 Hyaluronic Acid Viscosupplementation 57
2.4.3.1.1 Anika Therapeutics 57
2.4.3.1.2 Bioventus 58
2.4.3.1.3 Cairo University 59
2.4.3.1.4 Ferring Pharmaceuticals 59
2.4.3.1.5 Federal University of Minas Gerais 60
2.4.3.1.6 Fidia Pharma USA Inc. 60
2.4.3.1.7 Istituto Ortopedico Rizzoli 61
2.4.3.1.8 University Hospital 61
2.4.3.1.9 Universidade Nova de Lisboa 62

JAPAN ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW

3.1 INTRODUCTION 63
3.1.1 Bone Graft Substitutes 63
3.1.2 Growth Factors 63
3.1.3 Hyaluronic Acid (HA) Viscosupplementation 64
3.2 CURRENCY EXCHANGE RATE 65
3.3 MARKET OVERVIEW AND TREND ANALYSIS 66
3.4 DRIVERS AND LIMITERS 73
3.4.1 Market Drivers 73
3.4.2 Market Limiters 73
3.5 COMPETITIVE MARKET SHARE ANALYSIS 75
3.6 MERGERS AND ACQUISITIONS 79
3.7 COMPANY PROFILES 81
3.7.1 Anika Therapeutics 81
3.7.2 Bioventus 82
3.7.3 DePuy Synthes 83
3.7.4 Ferring Pharmaceuticals 84
3.7.5 Fidia Pharmaceuticals 85
3.7.6 Genzyme (Sanofi Group) 86
3.7.7 Harvest Technologies (Terumo BCT) 87
3.7.8 Integra LifeSciences 88
3.7.9 Medtronic 89
3.7.10 Musculoskeletal Transplant Foundation (MTF) 91
3.7.11 NuVasive 92
3.7.12 Orthofix 93
3.7.13 RTI Surgical 94
3.7.14 Stryker 95
3.7.15 Vericel Corporation (formerly Aastrom Bioscience) 96
3.7.16 Zimmer Biomet 97
3.8 SWOT ANALYSIS 99
3.8.1 Anika Therapeutics 99
3.8.2 Bioventus 101
3.8.3 DePuy Synthes 103
3.8.4 Ferring Pharmaceuticals 104
3.8.5 Fidia Pharmaceuticals 105
3.8.7 Harvest Technologies (Terumo BCT) 107
3.8.8 Integra LifeSciences 108
3.8.9 Medtronic 109
3.8.10 Musculoskeletal Transplant Foundation (MTF) 110
3.8.11 NuVasive 111
3.8.12 Orthofix 112
3.8.14 Stryker 114
3.8.15 Vericel Corporation (formerly Aastrom Bioscience) 115
3.8.16 Zimmer Biomet 116

PROCEDURE NUMBERS

4.1 INTRODUCTION 118
4.2 PROCEDURES 119
4.2.1 Orthopedic Biomaterial Procedures by Segment 119
4.2.2 Orthopedic Bone Grafting Procedures 121
4.2.2.1 Units per Procedure by Indication 123
4.2.2.2 Autograft Orthopedic Bone Grafting Procedures by Indication 124
4.2.2.3 Synthetic Orthopedic Bone Grafting Procedures by Indication 127
4.2.3 Hyaluronic Acid Supplementation Procedures 130
4.2.3.1 Hyaluronic Acid Supplementation Procedures by Injection Cycle 130

ORTHOPEDIC BONE GRAFT SUBSTITUTE MARKET

5.1 INTRODUCTION 132
5.2 MARKET ANALYSIS AND FORECAST 133
5.2.1.1 Synthetic Bone Graft Substitute Market 133
5.2.1.1.1 Synthetic Bone Graft Substitute Market by Indication 135
5.2.1.2 Demineralized Bone Matrix Allograft Bone Graft Substitute Market 161
5.3 DRIVERS AND LIMITERS 162
5.3.1 Market Drivers 162
5.3.2 Market Limiters 162
5.4 COMPETITIVE MARKET SHARE ANALYSIS 164

HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

6.1 INTRODUCTION 167
6.1.1 Benefits of Viscosupplementation 168
6.1.2 Synovial Fluid 168
6.2 MARKET OVERVIEW 169
6.3 MARKET ANALYSIS AND FORECAST 175
6.3.1 Total Hyaluronic Acid Viscosupplementation Market 175
6.3.2 Three-Injection Hyaluronic Acid Viscosupplementation Market 177
6.3.3 Five-Injection Hyaluronic Acid Viscosupplementation Market 179
6.4 DRIVERS AND LIMITERS 181
6.4.1 Market Drivers 181
6.4.2 Market Limiters 181
6.5 COMPETITIVE MARKET SHARE ANALYSIS 183

ABBREVIATIONS 187

The Orthobiologics Market Report Suite | Japan | 2020-2026 | MedSuite includes analysis on the following companies currently active in this market:

  • Chugai Pharma
  • CoorsTek
  • DePuy Synthes
  • HOYA Technosurgical
  • Kuraray
  • Maruho
  • Medtronic
  • Meiji Seika Pharma
  • NGKNTK
  • Olympus Terumo Biomaterials
  • Sanofi
  • Seikagaku
  • Stryker
  • Taisho
  • Wright Medical
  • Zimmer Biomet

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology